Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
Treatment with platelet-rich plasma (PRP) consists of extracting a small amount of blood from the patient himself, which is later processed by centrifugation to obtain a fraction rich in platelets. It will be done on weekly or fortnightly blood extraction procedure, depending on the process. Between 1-3 sterile citrate collection tubes will be used, which may vary depending on the size of the ulcer. Each tube can contain approximately 8-10ml of blood and the procedure is carried out under aseptic conditions and with material from a single use Once the sample has been centrifuged, the blood plasma will be extracted and the concentrate obtained will be applied directly on the wound or ulcer with the objective of stimulating and accelerating healing by means of growth factors.
This procedure is used as complementary therapy in chronic ulcers or with difficulty in healing, such as they can be venous, arterial, pressure or diabetic foot ulcers.
Full description
Introduction
Platelet-rich plasma (PRP) is an autologous blood derivative obtained by centrifuging the patient's own blood. It contains a high concentration of growth factors that promote tissue regeneration and cell proliferation. Its use in the treatment of chronic ulcers has shown good results, especially in wounds that do not respond to conventional treatments.
Required Materials
Sterile 5 ml and 10 ml syringes
Needles or butterfly needle and 20G vacutainer for extraction, and 30G (4 mm or 13 mm) for infiltration
Tube with anticoagulant (3.8% sodium citrate), closed system technique
Clinical centrifuge with fixed-angle or swinging-bucket rotor
Gloves, mask, gown, and sterile working surface
Sterile dressings, saline solution, and antiseptics
Blood Extraction
Draw between 10 and 20 ml of venous blood from the patient, depending on the extent of the ulcer. Use tubes with anticoagulant to prevent premature coagulation.
Apply a closed system technique to avoid handling and contamination of the sample.
Centrifugation
Use a single centrifugation cycle to obtain high-quality PRP: 3500 rpm for 10 minutes.
Once the process is complete, prepare the PRP in the selected 5 ml or 10 ml syringes.
PRP Application
→ Before application:
Clean the wound with saline solution and antiseptic.
Perform debridement if there is necrotic or fibrinous tissue.
→ Application methods:
Intradermal or subdermal perilesional infiltration using a fine needle (30G 4 mm or 30G 13 mm).
Direct application of PRP onto the wound bed.
Apply a topical layer.
Cover with a sterile dressing or gauze soaked in the same PRP.
Monitoring and Follow-Up
Evaluate the wound weekly or biweekly.
Repeat treatment every 1-2 weeks depending on progress.
Take photographs and document each visit to assess clinical response.
Contraindications and Precautions
Severe thrombocytopenia (< 100,000 platelets/μL)
Active systemic infection
Severe hematological disorders
Do not administer in case of allergy to the anticoagulants used
Active local infection
Conclusions
PRP represents an innovative and safe therapeutic option in the management of chronic ulcers, with good clinical outcomes and minimal side effects when performed using the appropriate technique.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
50 participants in 2 patient groups
Loading...
Central trial contact
Cristina G Granado Calvillo, Enfermeria; Cristina Z Zambrana Calderon, Enfermeria
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal